Overwatch 2's 45th hero is almost here but you don't need to wait until the next full moon (or, more accurately, Season 20's release date) to play her. Thanks to Vendetta's hero trial, you can put her ...

Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...

Boehringer Ingelheim has turned down its chance to license Nxera Pharma’s phase 2-ready schizophrenia drug candidate, depriving the Japanese drugmaker of a 60 million euro ($70 million) option payment ...

Vixarelimab showed significant symptom relief and disease progression reduction in prurigo nodularis compared with placebo across all doses. A phase 2b trial found vixarelimab rapidly reduced itch and ...

Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called ...

Denny Hamlin, the NASCAR driver and co-owner of 23XI Racing with Michael Jordan, returned to the witness stand on Day 2 of the NASCAR antitrust trial. From their own attorney, Hamlin fielded a ...

Forbes contributors publish independent expert analyses and insights. I have been chasing race cars since the first Michigan 500 in 1981. The second day of the NASCAR Anti-Trust Trial in Federal Court ...

Hamlin called the 2025 charter agreement that his 23XI Racing refused to sign "essentially my (team's) death certificate for the future." Meg Oliphant / Getty Images CHARLOTTE, N.C. — Three-time ...

Eli Lilly drug candidate retatrutide achieved up to 28.7% weight loss and reduced knee osteoarthritis pain in a phase 3 trial of 445 adults.

Adding stenting to intensive medical therapy significantly improves outcomes among patients with asymptomatic high-grade carotid stenosis compared with drug treatment alone, a bar not met by carotid ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too ...